RESMED INC (RMD) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Resmed Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Resmed Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was $4.77 B, a 16.7% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.77 B +$682 M +16.7% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $4.54 B +$620 M +15.8% Dec 31, 2023 10-Q 2024-01-25
Q3 2023 $4.4 B +$642 M +17.1% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $4.25 B +$639 M +17.7% Jun 30, 2023 10-Q 2024-04-26
Q1 2023 $4.09 B +$608 M +17.5% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $3.92 B +$558 M +16.6% Dec 31, 2022 10-Q 2023-01-27
Q3 2022 $3.76 B +$538 M +16.7% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $3.61 B +$534 M +17.3% Jun 30, 2022 10-K 2023-08-11
Q1 2022 $3.48 B +$539 M +18.3% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $3.36 B +$286 M +9.3% Dec 31, 2021 10-Q 2022-01-28
Q3 2021 $3.22 B +$268 M +9.09% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $3.08 B +$247 M +8.71% Jun 30, 2021 10-K 2022-08-12
Q1 2021 $2.94 B +$230 M +8.47% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $3.08 B +$472 M +18.1% Dec 31, 2020 10-Q 2021-01-29
Q3 2020 $2.95 B +$453 M +18.1% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $2.83 B +$397 M +16.3% Jun 30, 2020 10-K 2021-08-17
Q1 2020 $2.71 B +$291 M +12% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $2.6 B +$237 M +9.99% Dec 31, 2019 10-Q 2020-01-31
Q3 2019 $2.5 B +$204 M +8.89% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $2.44 B +$4.08 M +0.17% Jun 30, 2019 10-K 2020-08-13
Q1 2019 $2.42 B +$48.2 M +2.03% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $2.37 B +$56 M +2.42% Dec 31, 2018 10-Q 2019-02-01
Q3 2018 $2.3 B -$56.2 M -2.39% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $2.43 B +$116 M +5.01% Jun 30, 2018 10-K 2019-08-08
Q1 2018 $2.37 B +$111 M +4.91% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $2.31 B +$92.1 M +4.15% Dec 31, 2017 10-Q 2018-01-24
Q3 2017 $2.35 B +$163 M +7.43% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $2.32 B +$156 M +7.22% Jun 30, 2017 10-K 2018-08-17
Q1 2017 $2.26 B +$152 M +7.21% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $2.22 B +$157 M +7.63% Dec 31, 2016 10-Q 2017-01-25
Q3 2016 $2.19 B +$176 M +8.72% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $2.16 B +$184 M +9.33% Jun 30, 2016 10-K 2017-08-04
Q1 2016 $2.11 B +$181 M +9.41% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $2.06 B +$187 M +9.94% Dec 31, 2015 10-Q 2016-01-28
Q3 2015 $2.01 B +$190 M +10.4% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $1.98 B +$196 M +11% Jun 30, 2015 10-K 2016-08-05
Q1 2015 $1.93 B +$200 M +11.6% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $1.88 B +$203 M +12.2% Dec 31, 2014 10-Q 2015-01-30
Q3 2014 $1.82 B +$202 M +12.5% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $1.78 B +$204 M +12.9% Jun 30, 2014 10-K 2015-08-07
Q1 2014 $1.73 B +$200 M +13.1% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $1.67 B +$206 M +14% Dec 31, 2013 10-Q 2014-01-29
Q3 2013 $1.62 B +$208 M +14.7% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 $1.58 B +$210 M +15.4% Jun 30, 2013 10-K 2014-08-08
Q1 2013 $1.53 B +$238 M +18.5% Mar 31, 2013 10-Q 2013-05-01
Q4 2012 $1.47 B +$242 M +19.7% Dec 31, 2012 10-Q 2013-01-31
Q3 2012 $1.41 B +$251 M +21.6% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 $1.37 B +$255 M +22.9% Jun 30, 2012 10-K 2013-08-13
Q1 2012 $1.29 B +$236 M +22.4% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $1.23 B +$225 M +22.5% Dec 31, 2011 10-Q 2012-02-02
Q3 2011 $1.16 B +$221 M +23.4% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $1.11 B +$227 M +25.7% Jun 30, 2011 10-K 2012-08-14
Q1 2011 $1.05 B Mar 31, 2011 10-Q 2011-05-03
Q4 2010 $1 B Dec 31, 2010 10-Q 2011-02-03
Q3 2010 $942 M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $885 M Jun 30, 2010 10-K 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.